MXPA04006803A - Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma. - Google Patents
Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma.Info
- Publication number
- MXPA04006803A MXPA04006803A MXPA04006803A MXPA04006803A MXPA04006803A MX PA04006803 A MXPA04006803 A MX PA04006803A MX PA04006803 A MXPA04006803 A MX PA04006803A MX PA04006803 A MXPA04006803 A MX PA04006803A MX PA04006803 A MXPA04006803 A MX PA04006803A
- Authority
- MX
- Mexico
- Prior art keywords
- alpha
- treatment
- phenylthiocarboxylic
- phenyloxy
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Abstract
La presente invencion se refiere a compuestos de la formula (I) en los cuales los substituyentes tienen los significados descritos en el texto, y los cuales son utiles para el tratamiento de enfermedades que responden a la activacion de PPARa, tales como insuficiencia cardiaca, hiperlipemias y ateroesclerosis.(ver formula I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002RM000014A ITRM20020014A1 (it) | 2002-01-15 | 2002-01-15 | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
PCT/IT2003/000011 WO2003059875A2 (en) | 2002-01-15 | 2003-01-15 | DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04006803A true MXPA04006803A (es) | 2004-10-11 |
Family
ID=11455954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04006803A MXPA04006803A (es) | 2002-01-15 | 2003-01-15 | Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma. |
Country Status (17)
Country | Link |
---|---|
US (2) | US20050054671A1 (es) |
EP (1) | EP1474387B1 (es) |
JP (1) | JP2005514456A (es) |
KR (1) | KR100975961B1 (es) |
CN (1) | CN100522940C (es) |
AR (1) | AR038146A1 (es) |
AT (1) | ATE489361T1 (es) |
AU (1) | AU2003209679B2 (es) |
BR (1) | BR0306824A (es) |
CA (1) | CA2472223A1 (es) |
DE (1) | DE60335083D1 (es) |
HK (1) | HK1076625A1 (es) |
IT (1) | ITRM20020014A1 (es) |
MX (1) | MXPA04006803A (es) |
PL (1) | PL372666A1 (es) |
TW (1) | TW200305410A (es) |
WO (1) | WO2003059875A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7553867B2 (en) | 2002-09-06 | 2009-06-30 | Takeda Pharmaceutical Company Limited | Furan or thiophene derivative and medicinal use thereof |
ITRM20020629A1 (it) * | 2002-12-19 | 2004-06-20 | Sigma Tau Ind Farmaceuti | Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante. |
DE602004022179D1 (de) | 2003-09-19 | 2009-09-03 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga |
JP2007509921A (ja) * | 2003-10-28 | 2007-04-19 | ドクター・レディーズ・ラボラトリーズ・リミテッド | 新規化合物、および薬剤におけるそれらの使用:それらを調製する方法およびそれらを含有する薬学的組成物 |
BRPI0515015A (pt) * | 2004-08-11 | 2008-07-01 | Kyorin Seiyaku Kk | derivado cìclico de ácido aminobenzóico; medicamento; agonista ppar(alpha); agonista duplo ppar(alpha), y; agonista duplo ppar(alpha), (delta); modulador ppar; agente lipìdeo; agente profilático ou terapêutico compreendendo pelo menos um dos derivados cìclicos de ácido aminobenzóico ou sal do mesmo farmacêuticamente aceitável |
MY147518A (en) | 2004-09-15 | 2012-12-31 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
FR2880886B1 (fr) * | 2005-01-14 | 2007-04-06 | Merck Sante Soc Par Actions Si | Derives de l'acide 6-phenylhex-5-enoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique |
WO2006082495A1 (en) * | 2005-02-02 | 2006-08-10 | Ranbaxy Laboratories Limited | Peroxisome proliferator activated receptor modulators |
FR2882359A1 (fr) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | Derives activateurs de ppar, procede de preparation et application en therapeutique |
CN101189231B (zh) * | 2005-03-23 | 2011-05-18 | 杏林制药株式会社 | 环状氨基苯基链烷酸衍生物 |
JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
UY30288A1 (es) | 2006-04-18 | 2007-08-31 | Janssen Pharmaceutica Nv | Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol |
ES2745411T3 (es) * | 2006-07-27 | 2020-03-02 | Wang Nai Fang | Compuestos y composiciones de arilsulfanilo para administración de agentes activos |
JP5305818B2 (ja) * | 2008-10-03 | 2013-10-02 | キヤノン株式会社 | 生体情報取得装置 |
JP5669889B2 (ja) * | 2013-06-27 | 2015-02-18 | キヤノン株式会社 | 生体情報取得装置 |
CN106179111B (zh) * | 2016-07-16 | 2018-08-14 | 江南大学 | 一种由羧酸盐阴离子表面活性剂和二聚季铵盐形成的粘弹溶液 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1121722A (en) * | 1966-03-31 | 1968-07-31 | Ici Ltd | New carboxylic acid derivatives |
US3663540A (en) * | 1970-06-19 | 1972-05-16 | R & L Molecular Research Ltd | 7 - (p-aminomethylphenylthio)acetamido-3 -(pyridiniummethyl)ceph - 3 - em - 4-carboxylate |
US3965093A (en) * | 1971-09-24 | 1976-06-22 | E. R. Squibb & Sons, Inc. | 6-Arylthio penicillanic acid and derivatives thereof |
GB1422679A (en) * | 1972-11-16 | 1976-01-28 | Funai Pharmaceutical Ind Ltd | Substituted phenoxy-a-methylpropionic acid derivatives and a process for producing the same |
FR2285859A1 (fr) * | 1974-09-30 | 1976-04-23 | Lafon Labor | Phenylsulfinyl-amidines et derives |
DE2861187D1 (en) * | 1977-07-07 | 1981-12-24 | Ciba Geigy Ag | Phenoxy-phenylsulfinyl-and-sulfonylalkanecarboxylic acid derivatives, method for their preparation and their use as herbicides and plant growth regulators. |
JPH0311045A (ja) * | 1989-06-08 | 1991-01-18 | Hodogaya Chem Co Ltd | ベンズアミド誘導体 |
JPH06234732A (ja) * | 1992-09-10 | 1994-08-23 | Banyu Pharmaceut Co Ltd | 置換アセトアミド誘導体 |
FR2700166B1 (fr) * | 1993-01-07 | 1995-02-17 | Rhone Poulenc Rorer Sa | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. |
JP3583529B2 (ja) * | 1995-12-04 | 2004-11-04 | 富士写真フイルム株式会社 | ハロゲン化銀感光材料 |
DE69728267T2 (de) * | 1996-02-02 | 2005-02-24 | Merck & Co., Inc. | Antidiabetisches mittel |
WO1998005331A2 (en) | 1996-08-02 | 1998-02-12 | Ligand Pharmaceuticals Incorporated | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
US6197791B1 (en) * | 1997-02-27 | 2001-03-06 | American Cyanamid Company | N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
US6294573B1 (en) * | 1997-08-06 | 2001-09-25 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
EP1090013A1 (en) * | 1998-06-22 | 2001-04-11 | F. Hoffmann-La Roche Ag | Propenyl cephalosporin derivatives |
JP4618845B2 (ja) * | 1999-06-09 | 2011-01-26 | 杏林製薬株式会社 | ヒトペルオキシゾーム増殖薬活性化受容体(PPAR)αアゴニストとしての置換フェニルプロピオン酸誘導体 |
DE19940415A1 (de) * | 1999-08-26 | 2001-03-08 | Friedrich Spener | Verzweigtkettige Fettsäuren als fettabbauende Wirkstoffe |
US6525093B1 (en) * | 1999-11-08 | 2003-02-25 | Calyx Therapeutics Inc. | Compounds to treat diabetes and associated conditions |
WO2001055086A1 (en) * | 2000-01-28 | 2001-08-02 | Novo Nordisk A/S | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
EP1276710A1 (en) * | 2000-04-17 | 2003-01-22 | Novo Nordisk A/S | New compounds, their preparation and use |
AU2001258838A1 (en) * | 2000-05-29 | 2001-12-11 | Kyorin Pharmaceutical Co. Ltd. | Substituted phenylpropionic acid derivatives |
ATE368653T1 (de) * | 2000-08-23 | 2007-08-15 | Lilly Co Eli | Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten |
GB0111523D0 (en) * | 2001-05-11 | 2001-07-04 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-01-15 IT IT2002RM000014A patent/ITRM20020014A1/it unknown
-
2003
- 2003-01-15 CN CNB038022893A patent/CN100522940C/zh not_active Expired - Fee Related
- 2003-01-15 US US10/501,472 patent/US20050054671A1/en not_active Abandoned
- 2003-01-15 KR KR1020047010634A patent/KR100975961B1/ko not_active IP Right Cessation
- 2003-01-15 EP EP03729547A patent/EP1474387B1/en not_active Expired - Lifetime
- 2003-01-15 JP JP2003559979A patent/JP2005514456A/ja active Pending
- 2003-01-15 DE DE60335083T patent/DE60335083D1/de not_active Expired - Lifetime
- 2003-01-15 AR ARP030100103A patent/AR038146A1/es unknown
- 2003-01-15 AT AT03729547T patent/ATE489361T1/de not_active IP Right Cessation
- 2003-01-15 AU AU2003209679A patent/AU2003209679B2/en not_active Ceased
- 2003-01-15 WO PCT/IT2003/000011 patent/WO2003059875A2/en active Application Filing
- 2003-01-15 CA CA002472223A patent/CA2472223A1/en not_active Abandoned
- 2003-01-15 TW TW092101061A patent/TW200305410A/zh unknown
- 2003-01-15 BR BR0306824-2A patent/BR0306824A/pt not_active IP Right Cessation
- 2003-01-15 PL PL03372666A patent/PL372666A1/xx unknown
- 2003-01-15 MX MXPA04006803A patent/MXPA04006803A/es active IP Right Grant
-
2005
- 2005-09-29 HK HK05108606.4A patent/HK1076625A1/xx not_active IP Right Cessation
-
2007
- 2007-08-17 US US11/889,930 patent/US20080027098A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ITRM20020014A0 (it) | 2002-01-15 |
CN1620429A (zh) | 2005-05-25 |
PL372666A1 (en) | 2005-07-25 |
ITRM20020014A1 (it) | 2003-07-15 |
AR038146A1 (es) | 2004-12-29 |
CN100522940C (zh) | 2009-08-05 |
BR0306824A (pt) | 2004-12-21 |
AU2003209679A1 (en) | 2003-07-30 |
WO2003059875A3 (en) | 2003-12-04 |
US20050054671A1 (en) | 2005-03-10 |
KR100975961B1 (ko) | 2010-08-16 |
JP2005514456A (ja) | 2005-05-19 |
ATE489361T1 (de) | 2010-12-15 |
AU2003209679B2 (en) | 2009-02-19 |
EP1474387A2 (en) | 2004-11-10 |
KR20040068996A (ko) | 2004-08-02 |
TW200305410A (en) | 2003-11-01 |
WO2003059875A2 (en) | 2003-07-24 |
US20080027098A1 (en) | 2008-01-31 |
DE60335083D1 (de) | 2011-01-05 |
CA2472223A1 (en) | 2003-07-24 |
EP1474387B1 (en) | 2010-11-24 |
HK1076625A1 (en) | 2006-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04006803A (es) | Derivados de acidos alfa-feniltiocarboxilicos y alfa-feniloxi-carboxilicos para tratamiento de enfermedades que responden a activacion del receptor alfa activado del proliferador de peroxisoma. | |
RS115004A (en) | Novel thiophenylglycoside derivatives,methods for production thereof, medicaments comprising said compounds and use thereof | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
MXPA03009840A (es) | Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos. | |
TNSN04199A1 (en) | Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use | |
YU21401A (sh) | Tetrahidropiridoetri | |
MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
HRP20080664A2 (en) | Substituted pyridine herbicides | |
RS51445B (en) | PYROLIDINDION SUBSTITUTED BY PIPERIDINE-PTHALAZONE AS PDE4 INHIBITORS | |
EP1670450B8 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
WO2006100082A3 (de) | Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung | |
RS20050864A (en) | Novel pyridopyrazines and use thereof as kinase inhibitors | |
AU2002223058A1 (en) | Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling | |
TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
IL165558A0 (en) | N-benzoylureidocinnamate derivatives method for production and use thereof | |
EP1831239B8 (en) | A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process | |
MXPA05002489A (es) | Composiciones para el cuidado personal basadas en alcohol ramificado. | |
UY26133A1 (es) | Derivado sustituido de pirazol. | |
PT1601646E (pt) | Análogos da vitamina d e suas utilizações terapêuticas | |
TW200621703A (en) | Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
EA200601589A1 (ru) | Производные 7h-8,9-дигидропирано-(2,3-c)имидазо(1,2a)пиридина и их применение в качестве ингибиторов секреции кислоты желудочного сока | |
ATE386742T1 (de) | Imidazonaphthyridine | |
DE69823493D1 (de) | Tetrahydropyridoverbindungen | |
IS7365A (is) | Hvarfgjörn þynningarefni og húðir sem innihalda þau | |
ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |